Incyte
Pharmaceutical Research | Oncology Product Development | Incyte.com.
HQ location
Chadds Ford Township, United States
Website
Launch date
Employees
Market cap
$13.2b
Enterprise value
$10.9b
Share price
$68.10 INCY
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
$44.3m | Post IPO Equity | ||
| Total Funding | 000k | ||
Dorothy Koo Boulland(exited)
Paul Chirico(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 12 % | 14 % | 9 % | 15 % | 11 % | 10 % | 9 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 20 % | 19 % | 24 % | 8 % | 29 % | 33 % | 37 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 32 % | 10 % | 16 % | 1 % | 19 % | 23 % | 25 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 49 % | 47 % | 44 % | 61 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Incyte
Edit
ACQUISITION by Incyte Apr 2024
ACQUISITION by Incyte Oct 2022